Champions Oncology Inc (CSBR NASDAQ) stock market data APIs
$6.3746
0.64(10%)
as of September 17, 2025
Try our APIs with
free plan!
Champions Oncology Inc Financial Data Overview
Price chart is built with
Anychart
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Prev. Close
6.3746
Open
7.0125
High
7.1172
Low
6.3246
52 wk Range
3.75-11.99
Market Cap
87 556 K
P/E Ratio
19.2424
Shares Outstanding
13 788 K
Revenue
56 878 K
EPS
0.02
Beta
0.509
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Champions Oncology Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Champions Oncology Inc data using free add-ons & libraries
Get Champions Oncology Inc Fundamental Data
Champions Oncology Inc Fundamental data includes:
- Net Revenue: 56 878 K
- EBITDA: 4 559 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-09-09
- EPS/Forecast: 0.06
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Champions Oncology Inc News
New
Champions Oncology targets sequential revenue growth and margin expansion as radiopharma and data platforms advance
Earnings Call Insights: Champions Oncology (CSBR) Q1 2026 MANAGEMENT VIEW * Rob Brainin, CEO, stated that "fiscal 2025 is a pivotal year for Champions as we rebounded after a difficult 2024 to ach...
Champions Oncology Inc (NASDAQ:CSBR) Reports Q1 Fiscal 2026 Earnings with Record Revenue but Wider-Than-Expected Loss
Champions Oncology Inc (NASDAQ:CSBR [https://www.chartmill.com/stock/quote/CSBR]) reported its first-quarter fiscal 2026 earnings, posting record quarterly revenue of $14.0 million but falling short o...
Stocks Set to Open Higher as Investors Await Fed Meeting and U.S. Economic Data
September S&P 500 E-Mini futures (ESU25) are up +0.19%, andSeptember Nasdaq 100 E-Mini futures (NQU25) are up +0.08% this morning, pointing to a slightly higher open on Wall Street amid optimism ahead...
Champions Oncology earnings missed by $0.13, revenue fell short of estimates
Investing.com - Champions Oncology (NASDAQ: CSBR) reported first quarter EPS of $-0.070, $0.13 worse than the analyst estimate of $0.060. Revenue for the quarter came in at $12.36M versus the consen...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
